Request FREE sample PDF
Pharmacy benefit management market
DRONABINOL MARKET REPORT OVERVIEW
The global dronabinol market size was USD 235.7 million in 2022 and is expected to reach USD 447.71 million in 2031, exhibiting a CAGR of 6.6% during the forecast period.
People who are experiencing chemotherapy-related nausea and vomiting can be treated with dronabinol. Acute immunodeficiency syndrome patients who have hunger loss and weight loss can potentially benefit from the usage of this drugs. It is available in both a liquid and a capsule form. During chemotherapy, the capsule and liquid are taken three to four hours beforehand. Depending on the product it could be harmful. Don't take the medication in excess of what your doctor has suggested in terms of dosage, frequency, or duration. Only while you are taking the drug does medicine control the symptoms.
Usage this medication just as directed and never up the dosage, frequency, or duration of use. Your disease won't get better any faster, and you'll be at a higher risk for negative side effects. You can get withdrawal symptoms if you abruptly stop taking this drug (such as irritability, trouble sleeping, restlessness, hot flashes, diarrhea). Your doctor might gradually reduce your dose in order to help prevent withdrawal. If you have taken dronabinol frequently or in heavy dosages, withdrawal is more likely. If you experience withdrawal, tell your doctor or pharmacist straight away.
COVID-19 Impact: Disturbance in Supply Leads to Market Distortion
The global COVID-19 pandemic has been unprecedented and staggering, with dronabinol experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The rise in CAGR is attributable to the dronabinol market growth and demand returning to pre-pandemic levels once the pandemic is over.
There is no doubt that the COVID-19 pandemic had presented a challenge for healthcare companies in some way, causing market instability, declining customer confidence, and disruptions in import and export activity. Countries faced a huge decline in the production and supply chain. The COVID-19 outbreak hit the global dronabinol market leaving a trail of destruction in its awake. How we work and live has already been impacted by the pandemic. The epidemic has increased the number of AIDS-related fatalities in the ensuing years. The unprecedented changes to the supply and administration of market are also expected to drastically modify how people can get treatment given the widespread use of social distancing laws. Numerous of these modifications are having an extended impact. As they adjust to these new realities, businesses in every sector—including the healthcare industry—adopt new technology and methods of operation. The market had experienced a shortage of goods and materials, due to a lack of supplies in nature. Delivering services and large declines in research and clinical trial enrollment have made them more difficult; in addition, production instability and supply chain disruptions have an impact on the growth of the healthcare industry. With continuously growing healthcare sector across the globe the demand for the product is also growing rapidly and related equipment to support the operations. Demand rate of dronabinol market is expected to grow in traction during the forecast period.
LATEST TRENDS
"Dronabinol Oral Solution to Augment Market Growth"
The growing demand of dronabinol market are the main trend which is boosting the market. The medicine works by directly influencing the brain's areas that regulate appetite and vomiting, which causes an increase in hunger and a reduction in vomiting. The oral liquid is trending due to its perfect feature and it is easy to swallow. Most of the population has approved this new product and it is helping the market to boost and make its name.
DRONABINOL MARKET SEGMENTATION
- By Types
Based on type, the market is classified into Synthetic Dronabinol & Natural Dronabinol.
- By Application
Based on application, the market is categorized into Capsule & Oral Liquid.
DRIVING FACTORS
"Growing Number of People Suffering from AIDS to Boost Market Growth "
People suffering from immunodeficiency syndrome give the market boost because it creates the chance of products to grow and makes it name. As weight loss has been a common complaint for patients, the product helps the patient to make and improve their appetite that helps to lose their body fat which is the major concern of patients. Reducing body fat is important because it supports overall health and helps maintain the immune system. It also helps people with HIV maintain a healthy weight and absorb HIV medicines. HIV attacks and destroys the immune system, which makes it harder for the body to fight off infections. The domain is expected to experience enormous expansion as a result of the dronabinol market growth & overall needs.
"Curing Health Issues is What is Driving Market Expansion"
It can be used for many diseases which are not easily curable. It is used as a relief medicine to cure the nausea and vomiting. It can also be used as a treatment that cure chronic pain. Post-traumatic stress disorder can also be added in the list. Due to its multi-tasking feature, the market will reach new heights.
RESTRAINING FACTORS
"Market's Expansion is Anticipated to be Hampered by Product Side Effects"
It is not clear that the medicine creates any panic attack to the patient which is suffering from anxiety disorder but the medicine are likely not safe drugs for these patients because they can induce anxiety and panic attacks depending on each patient's doses and individual predispositions. It also creates stomach pain, dizziness in your body & headache. It is wise to let the doctor know what aide affects you are facing while using the medicine. But the proof of having any major drawback is very low and due to that side effects margin is very small.
DRONABINOL MARKET REGIONAL INSIGHTS
"North America Dominating the Market Across the Globe"
North America is a key consumer of the dronabinol market share, due to high prevalence of nausea associated with cancer chemotherapy and rising cases of anorexia. It still controls the majority of the world's demand and production of goods. North America region is home of many manufacturing companies which are the prime demanding sectors. The steady growth in production indices is estimated to be the prime driving factor for the demand of the product. Without a doubt, the market will grow significantly as demand rises.
KEY INDUSTRY PLAYERS
"Market Players to Foster Products Demand"
The research provides details on the list of market participants and their activity in the sector. Acquisitions, mergers, technical advancements, collaborations, and increasing production facilities are used to gather and report the information. The companies that produce and introduce new products, the areas where they operate, automation, technology adoption, creating the greatest income, and making a difference with their products are some of the other factors that are looked at for this market.
LIST OF TOP DRONABINOL COMPANIES
- Canopy Growth (Canada)
- Noramco (U.S.)
- Kineto Chem (U.S.)
- Entourage Phyto lab (Japan)
REPORT COVERAGE
Every facet of the market is investigated in the study, including market segmentation by type and application. A wide range of participants, including present and potential market leaders, are examined in the study. Significant market expansion is anticipated to be fueled by several important factors. The research also includes factors that are probably to increase dronabinol share in order to provide market insights. Additionally, market growth forecasts for the anticipated term are included in the research. Explaining why one region dominates the global market is the aim of the regional study. A number of problems, all of which are carefully evaluated, prevent the market from expanding. The study also includes a market strategic analysis. It includes thorough market information.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 235.7 Million in 2022 |
Market Size Value By |
US$ 447.71 Million by 2031 |
Growth Rate |
CAGR of 6.6% from 2022 to 2031 |
Forecast Period |
2024-2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type, Application & Region |
Frequently Asked Questions
-
What value is the dronabinol market expected to touch by 2031?
Based on our research, the dronabinol market is projected to touch USD 447.71 million by 2031.
-
What CAGR is the dronabinol market expected to exhibit by 2031?
The dronabinol market is expected to exhibit a CAGR of 6.6% by 2031.
-
Which are the driving factors of the dronabinol market?
Growing number of people suffering from AIDS to boost market growth & Curing health issues is what is driving market expansion were the two-driving factor of the dronabinol market.
-
What is the restraining factor of the dronabinol market?
Market expansion is anticipated to be hampered by product side effects.
-
Which are the segments of the dronabinol market?
Based on type, the dronabinol market is classified into Synthetic Dronabinol & Natural Dronabinol, based on application, the dronabinol market is categorized into Capsule & Oral Liquid, are the segments of the dronabinol market.